Nothing Special   »   [go: up one dir, main page]

WO2011044568A1 - Topical skin cream - Google Patents

Topical skin cream Download PDF

Info

Publication number
WO2011044568A1
WO2011044568A1 PCT/US2010/052256 US2010052256W WO2011044568A1 WO 2011044568 A1 WO2011044568 A1 WO 2011044568A1 US 2010052256 W US2010052256 W US 2010052256W WO 2011044568 A1 WO2011044568 A1 WO 2011044568A1
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
skin cream
producing
topical skin
container
Prior art date
Application number
PCT/US2010/052256
Other languages
French (fr)
Inventor
Mizell Ligon William
Original Assignee
Mizell Ligon William
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mizell Ligon William filed Critical Mizell Ligon William
Publication of WO2011044568A1 publication Critical patent/WO2011044568A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates generally to lotions and creams for the skin, and more particularly to an improved topical skin cream that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, including tinea versicolor, atopic dermatitis (eczema), plaque psoriasis, athlete's foot, rashes, chemical and industrial related itching, acne, and similar conditions.
  • an improved topical skin cream may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, including tinea versicolor, atopic dermatitis (eczema), plaque psoriasis, athlete's foot, rashes, chemical and industrial related itching, acne, and similar conditions.
  • United States Patent 5,322,685 to Nakagawa, et al. discloses a skin cream preparation for external use useful as a remedy for skin diseases which consists of a cream base comprising a diglycerol fatty acid ester and/or a sorbitan fatty acid ester having an HLB value of from 3 to 7, a polyvalent metal salt of a saturated or unsaturated fatty acid having 10 to 22 carbon atoms, an inorganic or organic acid salt, an oily phase component, and water together with an active ingredient.
  • United States Patent 6,348,199 to Vernice, et al. describes a clear, transparent highly stable skin moisturizing and lubricating composition obtained by combining polyglyceryl methacrylate with a pharmaceutically acceptable silicone, in the presence of a suitable emulsifier under application of pressure in the range of about 13,000 to about 50,000 psi.
  • the compositions are adapted for use as cosmetics and/or carriers for active drugs and serve in this form for treatment of skin irritations, burns, skin infections and the like.
  • a method of preparing the compositions of the invention is disclosed.
  • the invention also contemplates methods for lubricating and moisture replenishment of the skin, treating burns, skin infections and the like by topically applying the disclosed skin treatment compositions of the invention.
  • compositions for skin care are identical in lipid constituents and structural properties to that of human stratum corneum. They comprise the major constituents for the lipid lamellar of the stratum corneum, including ceramides, cholesterol and fatty acids, the major constituents for epidermal cell membranes, including phospholipids, and physiologically active substances, including phytosphingosine and its derivatives. Without causing side effects, the cream composition for skin care is of much better skin penetration and water-retention capacity than are conventional compositions comprised of ceramide and other components in forms different from those of human skin.
  • the cream composition brings about an improvement in the wrinkle condition of the skin, so that it can be applied to cosmetics. Also, it can be used as a medicinal material for the therapeutic treatment of inflammation, such as thermic erythema caused by IR and/or UV light.
  • United States Patent 6,932,976 to Brooks discloses an enzyme blocking skin protectant cream.
  • the skin protectant cream can be topically applied to protect skin from irritants, to block the action of irritants such as enzymes, and to treat skin that has been subject to irritants.
  • the cream can be applied manually or incorporated into disposable applicators, such as wipers or swabs.
  • the skin protectant cream is particularly useful in the prevention of severe skin breakdown which can lead to partial thickness skin wounds.
  • United States Patent 7,368,122 to Dow, et al. describes an emulsion for topical application to the skin containing a high molecular weight emulsifier and substantially no emulsifiers of a molecular weight less than 100 kD.
  • the emulsion may be used to prevent or treat dermatoses and may additionally contain pharmaceutically active ingredients.
  • United States Patent 7,557,094 to Wadstein teaches a skin cream composition containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a .beta.-cyclodextrin conjugated vitamin A.
  • the invention also concerns the preparation of the compositions.
  • the compositions according to the invention can be used as topical and cosmetic compositions as well as pharmaceutical compositions for treatment of atopical dermatitis, psoriasis eczema as well as eczema of different origins and solar dermatitis.
  • the present invention provides a topical skin cream comprising a mixture of sublimed sulfur powder, petroleum jelly (petrolatum, also known as soft paraffin), and baby oil (mineral oil), that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.
  • the inventive skin cream can be applied and left on overnight as recommended or can be used as a mask and washed off 15 to 20 minutes after the initial topical application. When used as directed, a visible difference may be observed in as little as two days. The overall color and texture of the skin to a more natural and balanced look may be observed within 7 to 8 days.
  • the method for producing the inventive topical skin cream preferably includes the steps of providing a quantity of petroleum jelly into a first container and heating until liquefaction; providing a quantity of Sublimed Sulfur Powder in a second container; transferring at least some of the liquefied petroleum jelly from the first container into the second container; stirring the mixture with a utensil to a paste-like consistency; adding a quantity of baby oil into the second container; stirring the mixture with a utensil to a cream-like consistency; allowing the mixture to settle; and packaging the mixture for use.
  • inventive skin cream may be produced as a pharmaceutical and has been successfully used to treat and relieve the symptoms of a variety of skin conditions, including but not limited to the following:
  • Tinea Versicolor is a fungal skin infection characterized by dry, flaky, itchy spots that are lighter/darker than the surrounding pigment. When the temperature and humidity are high the fungi grows rapidly and the normal pigment of your skin changes and spots appear. These spots form clusters of discolored pigments on the face, chest, upper body, back and upper legs.
  • Atopic Dermatitis also called eczema or atopic eczema is characterized by superficial skin inflammation and intense itching. This disorder is associated with dry skin. Heat and humidity as well as stress may trigger eczema. The exact cause of eczema is unknown.
  • Athlete's Foot is a skin infection of the foot caused by a fungus called Trichophyton. This fungus can thrive and infect the upper layer of skin. This infection can occur anywhere including the scalp, arms, legs, nails, groins and other areas of the body.
  • Mild Plaque Psoriasis is the most common type of psoriasis. The skin is red and covered with silvery scales and is inflamed, itch and burns. These plaque patches are usually found on the arms, legs, scalp or any part of the body. Psoriasis is not contagious and can be inherited.
  • Rash / Chemical Itch may be evidenced by a scaly patch of skin not caused by an infection but may be produced by fungal or bacterial infection as well as scabies. Intense itching that is aggravated by scratching develops from employment that handles any chemicals that is absorbed thru the skin. This itching can cause many sleepless nights.
  • Ichthyosis is a genetic skin disorder that has dry, thickened, scaly or flaky skin that resemble the scales of fish. The severity varies from the mildest type which may be mistaken for normal dry skin up to life threatening conditions such as harlequin type ichthyosis.
  • a further object or feature of the present invention is a new and improved skin cream that may be used to cleanse the skin.
  • An even further object of the present invention is to provide a novel skin cream that may be used as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.
  • All containers and mixing utensils that come into contact with or are used for mixing the materials for the inventive composition including, but not limited to: Sublimed Sulfur Powder, Petrolatum (petroleum jelly), and Baby Oil (mineral oil), are preferably non-metallic and/or have entirely non-metallic contact surfaces.
  • Sublimed Sulfur Powder, Petrolatum (petroleum jelly), and Baby Oil (mineral oil) are preferably non-metallic and/or have entirely non-metallic contact surfaces.
  • only wood, plastic, or glass containers and utensils are preferably used in any and all processes that contact and produce the inventive topical skin cream.
  • environmental and safety compatibility should be required so as to ensure there are no chemicals or substances given off from the container or surface into the mixture or product during the heating processes of production that may be harmful to human application.
  • Containers of other materials can be substituted for glass containers if similarly compatible.
  • Additional alternative mixing containers and utensils include ceramic, any type of natural stone including but not limited to granite, marble, quartz, and the like.
  • the inventive composition may also be able to be produced in any alternative container material with any alternative utensil material including stainless steel, aluminum, copper, or any other metal.
  • the composition ratio for the above-described composition intended for primary body application is 4 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (4:2: 1).
  • the composition ratio is preferably 8 parts sublimed sulfur powder, 4 parts liquefied petroleum jelly, and 1 part baby oil (8:4: 1).
  • the composition ratio is preferably 5 parts sublimed sulfur powder, 3 parts liquefied petroleum jelly, and 1 part baby oil (5:3: 1).
  • the composition ratio is preferably 3 1/3 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (3 1/3:2: 1).
  • the composition ratio is preferably 6 parts sublimed sulfur powder, 3 parts solid petroleum jelly, and 1 part baby oil (6:3: 1).
  • the above embodiments of the inventive composition comprise approximately 53-62% sublimed sulfur powder, 29-33% petroleum jelly, and 8-16% baby oil. These ratios and percentages may be adjusted as appropriate for different applications, for example, from 25-90%) sublimed sulfur powder, 15-50%) petroleum jelly, and 4- 25% baby oil. In all cases, the production process is preferably the same.
  • ingredients that may be used in the production of the inventive topical skin cream include, but are not limited to, the following: Absolute alcohol, Absorbase, Acid Mantle, Aloe Vera juice, Aloe Vera gel, Aluminum sulfate, Aquabase,

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A topical skin cream composition and a method for its production, the composition comprising a mixture of sublimed sulfur powder, petroleum jelly (petrolatum), and baby oil (mineral oil), that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.

Description

TOPICAL SKIN CREAM
Inventor:
Mizell Ligon Williams
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] The present application claims the benefit of the filing date of U.S. Provisional Patent Application Serial No. 61/278,594, filed 10/09/2009; U.S. Provisional Patent Application Serial No. 61/335,599, filed 01/1 1/2010; and U.S. Provisional Patent Application Serial No. 61/350,556, filed 06/02/2010. The foregoing applications are incorporated by reference in their entirety as if fully set forth herein.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
[0002] Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
[0003] Not applicable. TECHNICAL FIELD
[0004] The present invention relates generally to lotions and creams for the skin, and more particularly to an improved topical skin cream that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, including tinea versicolor, atopic dermatitis (eczema), plaque psoriasis, athlete's foot, rashes, chemical and industrial related itching, acne, and similar conditions.
BACKGROUND INFORMATION AND DISCUSSION OF RELATED ART
[0005] United States Patent 5,322,685 to Nakagawa, et al. discloses a skin cream preparation for external use useful as a remedy for skin diseases which consists of a cream base comprising a diglycerol fatty acid ester and/or a sorbitan fatty acid ester having an HLB value of from 3 to 7, a polyvalent metal salt of a saturated or unsaturated fatty acid having 10 to 22 carbon atoms, an inorganic or organic acid salt, an oily phase component, and water together with an active ingredient.
[0006] United States Patent 6,348,199 to Vernice, et al. describes a clear, transparent highly stable skin moisturizing and lubricating composition obtained by combining polyglyceryl methacrylate with a pharmaceutically acceptable silicone, in the presence of a suitable emulsifier under application of pressure in the range of about 13,000 to about 50,000 psi. The compositions are adapted for use as cosmetics and/or carriers for active drugs and serve in this form for treatment of skin irritations, burns, skin infections and the like. A method of preparing the compositions of the invention is disclosed. The invention also contemplates methods for lubricating and moisture replenishment of the skin, treating burns, skin infections and the like by topically applying the disclosed skin treatment compositions of the invention.
[0007] United States Patent 6,372,236 to Park, et al. teaches cream compositions for skin care. The compositions are identical in lipid constituents and structural properties to that of human stratum corneum. They comprise the major constituents for the lipid lamellar of the stratum corneum, including ceramides, cholesterol and fatty acids, the major constituents for epidermal cell membranes, including phospholipids, and physiologically active substances, including phytosphingosine and its derivatives. Without causing side effects, the cream composition for skin care is of much better skin penetration and water-retention capacity than are conventional compositions comprised of ceramide and other components in forms different from those of human skin. In addition to providing inhibitory activity against skin microorganisms, the cream composition brings about an improvement in the wrinkle condition of the skin, so that it can be applied to cosmetics. Also, it can be used as a medicinal material for the therapeutic treatment of inflammation, such as thermic erythema caused by IR and/or UV light.
[0008] United States Patent 6,932,976 to Brooks discloses an enzyme blocking skin protectant cream. The skin protectant cream can be topically applied to protect skin from irritants, to block the action of irritants such as enzymes, and to treat skin that has been subject to irritants. The cream can be applied manually or incorporated into disposable applicators, such as wipers or swabs. The skin protectant cream is particularly useful in the prevention of severe skin breakdown which can lead to partial thickness skin wounds. [0009] United States Patent 7,368,122 to Dow, et al. describes an emulsion for topical application to the skin containing a high molecular weight emulsifier and substantially no emulsifiers of a molecular weight less than 100 kD. The emulsion may be used to prevent or treat dermatoses and may additionally contain pharmaceutically active ingredients.
[0010] United States Patent 7,557,094 to Wadstein teaches a skin cream composition containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a .beta.-cyclodextrin conjugated vitamin A. The invention also concerns the preparation of the compositions. The compositions according to the invention can be used as topical and cosmetic compositions as well as pharmaceutical compositions for treatment of atopical dermatitis, psoriasis eczema as well as eczema of different origins and solar dermatitis.
[0011] The foregoing patents reflect the current state of the art of which the present inventor is aware. Reference to, and discussion of, these patents is intended to aid in discharging Applicant's acknowledged duty of candor in disclosing information that may be relevant to the examination of claims to the present invention. However, it is respectfully submitted that none of the above- indicated patents disclose, teach, suggest, show, or otherwise render obvious, either singly or when considered in combination, the invention described and claimed herein.
SUMMARY OF THE INVENTION
[0012] The present invention provides a topical skin cream comprising a mixture of sublimed sulfur powder, petroleum jelly (petrolatum, also known as soft paraffin), and baby oil (mineral oil), that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions. The inventive skin cream can be applied and left on overnight as recommended or can be used as a mask and washed off 15 to 20 minutes after the initial topical application. When used as directed, a visible difference may be observed in as little as two days. The overall color and texture of the skin to a more natural and balanced look may be observed within 7 to 8 days.
[0013] The method for producing the inventive topical skin cream preferably includes the steps of providing a quantity of petroleum jelly into a first container and heating until liquefaction; providing a quantity of Sublimed Sulfur Powder in a second container; transferring at least some of the liquefied petroleum jelly from the first container into the second container; stirring the mixture with a utensil to a paste-like consistency; adding a quantity of baby oil into the second container; stirring the mixture with a utensil to a cream-like consistency; allowing the mixture to settle; and packaging the mixture for use.
[0014] The inventive skin cream may be produced as a pharmaceutical and has been successfully used to treat and relieve the symptoms of a variety of skin conditions, including but not limited to the following:
[0015] Tinea Versicolor is a fungal skin infection characterized by dry, flaky, itchy spots that are lighter/darker than the surrounding pigment. When the temperature and humidity are high the fungi grows rapidly and the normal pigment of your skin changes and spots appear. These spots form clusters of discolored pigments on the face, chest, upper body, back and upper legs.
[0016] Atopic Dermatitis also called eczema or atopic eczema is characterized by superficial skin inflammation and intense itching. This disorder is associated with dry skin. Heat and humidity as well as stress may trigger eczema. The exact cause of eczema is unknown.
[0017] Athlete's Foot is a skin infection of the foot caused by a fungus called Trichophyton. This fungus can thrive and infect the upper layer of skin. This infection can occur anywhere including the scalp, arms, legs, nails, groins and other areas of the body.
[0018] Mild Plaque Psoriasis is the most common type of psoriasis. The skin is red and covered with silvery scales and is inflamed, itch and burns. These plaque patches are usually found on the arms, legs, scalp or any part of the body. Psoriasis is not contagious and can be inherited.
[0019] Rash / Chemical Itch may be evidenced by a scaly patch of skin not caused by an infection but may be produced by fungal or bacterial infection as well as scabies. Intense itching that is aggravated by scratching develops from employment that handles any chemicals that is absorbed thru the skin. This itching can cause many sleepless nights.
[0020] Ichthyosis is a genetic skin disorder that has dry, thickened, scaly or flaky skin that resemble the scales of fish. The severity varies from the mildest type which may be mistaken for normal dry skin up to life threatening conditions such as harlequin type ichthyosis.
[0021] It is therefore an object of the present invention to provide a new and improved topical skin cream.
[0022] It is another object of the present invention to provide a new and improved skin cream that may be used to beautify and improve the overall appearance of the skin.
[0023] A further object or feature of the present invention is a new and improved skin cream that may be used to cleanse the skin.
[0024] An even further object of the present invention is to provide a novel skin cream that may be used as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.
[0025] Other novel features which are characteristic of the invention, as to organization and method of operation, together with further objects and advantages thereof will be better understood from the following description considered in connection with the accompanying drawings, in which preferred embodiments of the invention are illustrated by way of example. It is to be expressly understood, however, that the drawings are for illustration and description only and are not intended as a definition of the limits of the invention. The various features of novelty which characterize the invention are pointed out with particularity in the claims annexed to and forming part of this disclosure. The invention resides not in any one of these features taken alone, but rather in the particular combination of all of its structures for the functions specified.
[0026] There has thus been broadly outlined the more important features of the invention in order that the detailed description thereof that follows may be better understood, and in order that the present contribution to the art may be better appreciated. There are, of course, additional features of the invention that will be described hereinafter and which will form additional subject matter of the claims appended hereto. Those skilled in the art will appreciate that the conception upon which this disclosure is based readily may be utilized as a basis for the designing of other structures, methods and systems for carrying out the several purposes of the present invention. It is important, therefore, that the claims be regarded as including such equivalent constructions insofar as they do not depart from the spirit and scope of the present invention.
[0027] Further, the purpose of the Abstract is to enable the U.S. Patent and Trademark Office and the public generally, and especially the scientists, engineers and practitioners in the art who are not familiar with patent or legal terms or phraseology, to determine quickly from a cursory inspection the nature and essence of the technical disclosure of the application. The Abstract is neither intended to define the invention of this application, which is measured by the claims, nor is it intended to be limiting as to the scope of the invention in any way.
[0028] Certain terminology and derivations thereof may be used in the following description for convenience in reference only, and will not be limiting. For example, words such as
"upward," "downward," "left," and "right" would refer to directions in the drawings to which reference is made unless otherwise stated. Similarly, words such as "inward" and "outward" would refer to directions toward and away from, respectively, the geometric center of a device or area and designated parts thereof. References in the singular tense include the plural, and vice versa, unless otherwise noted.
DETAILED DESCRIPTION OF THE INVENTION
[0029] The following is a description of a preferred method for producing a particular limited quantity of a primary body application of the topical skin cream of the present invention. The respective amounts of the indicated ingredients may of course be adjusted or scaled to produce different quantities of end product, as is well known in the art.
[0030] All containers and mixing utensils that come into contact with or are used for mixing the materials for the inventive composition including, but not limited to: Sublimed Sulfur Powder, Petrolatum (petroleum jelly), and Baby Oil (mineral oil), are preferably non-metallic and/or have entirely non-metallic contact surfaces. For example, only wood, plastic, or glass containers and utensils are preferably used in any and all processes that contact and produce the inventive topical skin cream. In the case of a container or surface defined within the poly or plastics family, environmental and safety compatibility should be required so as to ensure there are no chemicals or substances given off from the container or surface into the mixture or product during the heating processes of production that may be harmful to human application. Containers of other materials can be substituted for glass containers if similarly compatible. Additional alternative mixing containers and utensils include ceramic, any type of natural stone including but not limited to granite, marble, quartz, and the like. The inventive composition may also be able to be produced in any alternative container material with any alternative utensil material including stainless steel, aluminum, copper, or any other metal.
[0031] All measurements are in net weight US ounces. All conditions are standard room temperature and mean sea level atmospheric pressure or standard room pressure if equivalent unless otherwise noted. Humidity conditions should not exceed 50% during the entire process.
[0032] 1. Place a quantity of room temperature petroleum jelly into a first glass container and heat to 175 degrees Fahrenheit for a minimum of 15 minutes or until liquefaction begins to occur.
[0033] 2. Once liquefaction begins to occur slowly stir petroleum jelly with non-metallic instrument or utensil until the jelly reaches consistent visible clarity or translucency throughout.
[0034] 3. Separately: Place one dry ounce (1 oz.) [or a corresponding ratio] of Sublimed Sulfur Powder in a second clean glass container at room temperature and at mean sea level atmospheric pressure and/or standard room atmospheric pressure.
[0035] 4. Pour ½ ounce (.50 oz.) [or a corresponding ratio] of the liquefied petroleum jelly from the first container into the second container containing the 1 oz. of sublimed sulfur powder.
[0036] 5. Moderately stir mixture with a non-metallic utensil, spatula, or mixing blade made out of glass, wood, or plastic, or that is entirely glass coated or entirely plastic coated for 15 to 30 minutes at room temperature and standard pressure to a paste-like consistency. For large production batches, 30 to 60 minutes may be required.
[0037] 6. Add ¼ ounce (.25 oz.) [or a corresponding ratio] of baby oil into the second container containing the mixture of sublimed sulfur powder and liquefied petroleum jelly, which has now cooled to a paste-like product.
[0038] 7. Moderately stir mixture with a non-metallic utensil, spatula, or mixing blade made out of glass, wood, or plastic, or that is entirely glass coated or entirely plastic coated for 15 to 30 minutes at room temperature and standard pressure to a cream-like consistency. For large batch production, 30 to 60 minutes may be required.
[0039] 8. Allow mixture to set at room temperature and standard conditions for 24 hours.
[0040] 9. After the 24 hour settling, remix the product for 15 to 30 minutes at room
temperature.
[0041] 9a. Alternatively, after the 24 hour settling, heat the product to 100 to 110 degrees Fahrenheit for 60 minutes. Remove heat source. Stir for 15 to 30 minutes while product cools to room temperature.
[0042] 9b. Optionally, after the 24 hour settling, remix the product for 15 to 30 minutes at room temperature, then heat the product to 100 to 110 degrees Fahrenheit at standard room conditions while maintaining the mixing process. Continue mixing for 30 minutes at 100 to 110 degrees Fahrenheit. Longer if necessary in order to achieve desired cream-like consistency. Reduce heating source to room temperature and continue mixing until product cools to room temperature. Approximately another 30 to 60 minutes.
[0043] 10. Dispense product into appropriately sized plastic or glass containers or tubes for public distribution using non-metallic instruments and/or production and processing lines. If bottles are used, seal the top of the bottle with a paper, plastic, or foam material. Then place the lid on the bottle. An alternative to sealing the top of the bottle is to have a foam liner inside of the lid.
[0044] 11. Allow to sit for 24 hours before shipping. Shelf life is approximately 60 days.
[0045] The composition ratio for the above-described composition intended for primary body application is 4 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (4:2: 1). For a primary facial and/or masque application, the composition ratio is preferably 8 parts sublimed sulfur powder, 4 parts liquefied petroleum jelly, and 1 part baby oil (8:4: 1). For a primary travel tube for body or face application (e.g., a thinner, creamier type of product, suitable for packaging and use in a squeeze type of container such as a tooth paste tube screw top or suntan lotion type pop-top container), the composition ratio is preferably 5 parts sublimed sulfur powder, 3 parts liquefied petroleum jelly, and 1 part baby oil (5:3: 1). For an alternative for body use application, the composition ratio is preferably 3 1/3 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (3 1/3:2: 1). For an alternative for masque use only application, the composition ratio is preferably 6 parts sublimed sulfur powder, 3 parts solid petroleum jelly, and 1 part baby oil (6:3: 1). Generally, the above embodiments of the inventive composition comprise approximately 53-62% sublimed sulfur powder, 29-33% petroleum jelly, and 8-16% baby oil. These ratios and percentages may be adjusted as appropriate for different applications, for example, from 25-90%) sublimed sulfur powder, 15-50%) petroleum jelly, and 4- 25% baby oil. In all cases, the production process is preferably the same.
[0046] Additional and alternative ingredients that may be used in the production of the inventive topical skin cream include, but are not limited to, the following: Absolute alcohol, Absorbase, Acid Mantle, Aloe Vera juice, Aloe Vera gel, Aluminum sulfate, Aquabase,
Aquaphilic, Aquaphilic with Carbamide 10%> and 20%, Aquaphor Natural Healing, C-Solve, Chamomile essence, Calcium acetate, Carbomer-940, Ceresin wax, Ceteareth-20, Cetearyl alcohol, Cetostearyl alcohol, Cetyl alcohol, Cetyl esters, Cholesterol, Collagen, Dermabase, Dermovan, E-Solve, Eucerin, Glycerin, Glyceryl monostearate, Glyceryl stearate, Hydrocream Base, Hydrolyzed animal protein, Hydroxyethyl cellulose, Hydroxypropyl cellulose, Hydrophilic, Imidazolidinyl urea, Isopropyl alcohol, Iron Oxides, Isopropyl palmitate, Lactic Acid, Lanaphilic, Lanaphilic with Urea 10%, Lanolin Oil, Lauramide-DEA, Laureth-4, Methylparaben, Mineral Wax, Nutraderm, Panthenol, Parabens, PEG-8, PEG-75, Polyethylene Glycol, Polyethylene glycol monostearate, Polysorbate 20, Polysorbate 80, Polyvinlypyrrolidone, Potassium sorbate, Propylene glycol, Propylparaben, SD Alcohol 40, SD Alcohol 40B, Simethicone, Sodium cetearyl sulfate, Sodium Lauryl Sulfate, Solumol, Solvent-G, Sorbitan sesquioleate, Sorbitan stearate, Sorbitol, Sorbitol solution, Stearamidoethyl diethylamine, Stearyl alcohol, Synthetic beeswax, Talc, Triethanolamine, Titanium dioxide, Unibase, Urea, Vanicream, Vehicle/N, Vehicle/N Mild, Velvachol, Vitamin E, Vitamin E gel, Water, White petrolatum, White potato dextrin, and Woolwax alcohol.
[0047] The above disclosure is sufficient to enable one of ordinary skill in the art to practice the invention, and provides the best mode of practicing the invention presently contemplated by the inventor. While there is provided herein a full and complete disclosure of the preferred embodiments of this invention, it is not desired to limit the invention to the exact construction, dimensional relationships, and operation shown and described. Various modifications, alternative constructions, changes and equivalents will readily occur to those skilled in the art and may be employed, as suitable, without departing from the true spirit and scope of the invention. Such changes might involve alternative materials, components, structural arrangements, sizes, shapes, forms, functions, operational features or the like.
[0048] Therefore, the above description and illustrations should not be construed as limiting the scope of the invention, which is defined by the appended claims.

Claims

CLAIMS What is claimed as invention is:
1. A topical skin cream that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, said skin cream comprising a mixture of sublimed sulfur powder, petroleum jelly (petrolatum), and baby oil (mineral oil).
2. The topical skin cream of claim 1 comprising from 25-90% sublimed sulfur powder, 15-50% petroleum jelly, and 4-25% baby oil.
3. The topical skin cream of claim 1 comprising from 53-62% sublimed sulfur powder, 29-33%) petroleum jelly, and 8-16% baby oil.
4. A method for producing a topical skin cream that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, said method comprising the steps of:
providing a quantity of petroleum jelly into a first container and heating until liquefaction;
providing a quantity of Sublimed Sulfur Powder in a second container;
transferring at least some of the liquefied petroleum jelly from the first container into the second container;
stirring the mixture with a utensil to a paste-like consistency;
adding a quantity of baby oil into the second container;
stirring the mixture with a utensil to a cream-like consistency;
allowing the mixture to settle; and
packaging the mixture for use.
5. The method for producing a topical skin cream of claim 4 wherein said step of providing a quantity of petroleum jelly into a first container and heating until liquefaction further includes stirring the petroleum jelly with a utensil until the petroleum jelly reaches consistent translucency throughout.
6. The method for producing a topical skin cream of claim 4 wherein said step of allowing the mixture to settle further includes the step of remixing the mixture prior to packaging.
7 The method for producing a topical skin cream of claim 4 wherein said step of allowing the mixture to settle further includes the step of reheating the mixture, removing the heat source, and stirring the mixture while it cools prior to packaging.
8. The method for producing a topical skin cream of claim 4 wherein said step of allowing the mixture to settle further includes the step of remixing the mixture at room temperature, then heating the mixture while maintaining the mixing process to achieve a creamlike consistency, then removing the heat source and continue mixing until the mixture cools to room temperature prior to packaging.
9. The method for producing a topical skin cream of claim 4 wherein the first container is nonmetallic.
10. The method for producing a topical skin cream of claim 4 wherein the first container is glass.
11. The method for producing a topical skin cream of claim 4 wherein the second container is nonmetallic.
12. The method for producing a topical skin cream of claim 4 wherein the second container is glass.
13. The method for producing a topical skin cream of claim 4 wherein the utensil is nonmetallic.
14. The method for producing a topical skin cream of claim 4 wherein the utensil is glass.
15. The method for producing a topical skin cream of claim 4 wherein the quantity of sublimed sulfur powder comprises from 25-90% of the mixture.
16. The method for producing a topical skin cream of claim 4 wherein the quantity of sublimed sulfur powder comprises from 53-62% of the mixture.
17. The method for producing a topical skin cream of claim 4 wherein the quantity of petroleum jelly comprises from 15-50% of the mixture.
18. The method for producing a topical skin cream of claim 4 wherein the quantity of petroleum jelly comprises from 29-33% of the mixture.
19. The method for producing a topical skin cream of claim 4 wherein the quantity of baby oil comprises from 4-25% of the mixture.
20. The method for producing a topical skin cream of claim 4 wherein the quantity of baby oil comprises from 8-16% of the mixture.
PCT/US2010/052256 2009-10-09 2010-10-12 Topical skin cream WO2011044568A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US27859409P 2009-10-09 2009-10-09
US61/278,594 2009-10-09
US33559910P 2010-01-11 2010-01-11
US61/335,599 2010-01-11
US35055610P 2010-06-02 2010-06-02
US61/350,556 2010-06-02

Publications (1)

Publication Number Publication Date
WO2011044568A1 true WO2011044568A1 (en) 2011-04-14

Family

ID=43857186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/052256 WO2011044568A1 (en) 2009-10-09 2010-10-12 Topical skin cream

Country Status (1)

Country Link
WO (1) WO2011044568A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175888A1 (en) * 2015-12-02 2017-06-07 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192866A (en) * 1978-10-10 1980-03-11 Ralph Anderson Anorectal medication
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
US20050064047A1 (en) * 2003-09-24 2005-03-24 Brian Penick Composition and method for treating skin disorders
US20060142587A1 (en) * 2004-11-08 2006-06-29 L'oreal Benzoisothiazolone compositions
US20060188459A1 (en) * 2005-02-22 2006-08-24 Franz-Leo Heinrichs Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US20090155383A1 (en) * 2007-10-26 2009-06-18 David Johnathan Kitko Personal Care Compositions Comprising Undecyl Sulfates
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192866A (en) * 1978-10-10 1980-03-11 Ralph Anderson Anorectal medication
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
US20050064047A1 (en) * 2003-09-24 2005-03-24 Brian Penick Composition and method for treating skin disorders
US20060142587A1 (en) * 2004-11-08 2006-06-29 L'oreal Benzoisothiazolone compositions
US20060188459A1 (en) * 2005-02-22 2006-08-24 Franz-Leo Heinrichs Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US20090155383A1 (en) * 2007-10-26 2009-06-18 David Johnathan Kitko Personal Care Compositions Comprising Undecyl Sulfates
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175888A1 (en) * 2015-12-02 2017-06-07 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof
US10238685B2 (en) 2015-12-02 2019-03-26 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof
AU2016266017B2 (en) * 2015-12-02 2022-09-29 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof

Similar Documents

Publication Publication Date Title
WO2013067185A1 (en) Probiotic stick formulation for skin maintenance and methods of use
TW200526260A (en) Cosmetic composition and methods
JP2007045776A (en) Humectant and cosmetic and skin care preparation for external use by using the same
JP2009155227A (en) Living body tissue repair promoting drug
US20230099298A1 (en) Cosmetic mask for application to the skin, and method for applying same
RU2591789C1 (en) Cosmetic composition for face and neck skin care
JP3908126B2 (en) Epidermal keratinization normalizing agent and skin external preparation containing the same
JP2009161564A (en) Therapeutic composition for atopic dermatitis
JP4288306B2 (en) Cosmetics containing dimer dilinoleic acid diethylene glycol oligomer ester
JP4005917B2 (en) Cholesterol sulfate and amino sugar composition for improving the function of the stratum corneum
Eberting et al. Repairing a compromised skin barrier in dermatitis: leveraging the skin’s ability to heal itself
KR101460777B1 (en) Cosmetic composition for improving acne
CN110448518A (en) A kind of preparation method of whitening body lotion
WO2011044568A1 (en) Topical skin cream
JP3507635B2 (en) Composition suitable for external use
JP6001840B2 (en) Drugs for living tissue
RU2715231C1 (en) Cosmetic face mask film for face skin care with vitamins in liposomes
JP2003104886A (en) Skin care composition
JP6664883B2 (en) External composition
JP2003342179A (en) Agent for aging prevention
JP5171752B2 (en) Topical skin preparation
JP7529377B2 (en) Eyelid skin surface impression improving agent and screening method thereof
CN110755349A (en) Allicin shining pigment cream and preparation method thereof
KR101814538B1 (en) A cosmentic composition comprising the bio-cellulose powder for reducing and preventing cellulite
KR101814537B1 (en) A skin topical composition comprising the bio-cellulose powder for reducing and preventing cellulite

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822828

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 10822828

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE